This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Lead Chemical Company, Limited. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Seijirou Yama: Innovator in Nonsteroidal Anti-Inflammatory Analgesics
Introduction
Seijirou Yama is a notable inventor based in Toyama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of nonsteroidal anti-inflammatory analgesics. His innovative approach has led to advancements in drug delivery systems.
Latest Patents
Yama holds a patent for a nonaqueous preparation for percutaneous absorption containing a nonsteroidal anti-inflammatory analgesic. This invention relates to a unique formulation that enhances drug-releasing characteristics and skin penetration. By laminating an adhesive layer with an alkali metal salt form of the analgesic and a strongly acidic inorganic acid, Yama's preparation improves the solubility of the drug in a nonaqueous base. This results in better partitioning of the drug to the skin surface, ensuring effective delivery without compromising the drug's stability.
Career Highlights
Seijirou Yama has dedicated his career to research and development in the pharmaceutical industry. He is currently associated with Lead Chemical Company, Limited, where he continues to innovate and refine drug formulations. His work has been instrumental in enhancing the efficacy of pain management therapies.
Collaborations
Yama collaborates with Naoki Murai, contributing to the advancement of pharmaceutical technologies. Their partnership focuses on improving drug delivery systems and exploring new therapeutic options.
Conclusion
Seijirou Yama's contributions to the field of nonsteroidal anti-inflammatory analgesics highlight his innovative spirit and dedication to improving healthcare. His patented formulation represents a significant step forward in drug delivery technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile